CONCERT PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2018 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Concert Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2018 to Q3 2022.
  • Concert Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $8.21M, a 5.55% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $8.21M -$482K -5.55% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $8.34M -$448K -5.1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $8.47M -$415K -4.67% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $8.59M -$383K -4.27% Dec 31, 2021 10-Q 2022-11-07
Q3 2021 $8.69M -$354K -3.91% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $8.79M -$326K -3.58% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $8.88M -$300K -3.27% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $8.97M -$284K -3.07% Dec 31, 2020 10-K 2022-03-03
Q3 2020 $9.05M -$271K -2.91% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $9.12M -$258K -2.75% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $9.18M -$246K -2.61% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $9.25M +$9.25M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $9.32M +$9.32M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $9.38M +$9.38M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $9.43M +$9.43M Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-07
Q3 2018 $0 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $0 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $0 Mar 31, 2018 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.